Page last updated: 2024-09-04

glucagon and alogliptin

glucagon has been researched along with alogliptin in 3 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(alogliptin)
Trials
(alogliptin)
Recent Studies (post-2010) (alogliptin)
26,0391,4983,05430280261

Protein Interaction Comparison

ProteinTaxonomyglucagon (IC50)alogliptin (IC50)
Cytochrome P450 1A2Homo sapiens (human)10
Cytochrome P450 3A4Homo sapiens (human)10
Cytochrome P450 2D6Homo sapiens (human)10
Cytochrome P450 2C9 Homo sapiens (human)10
Dipeptidyl peptidase 4Homo sapiens (human)0.0066
Cytochrome P450 2C19Homo sapiens (human)10
Dipeptidyl peptidase 8Homo sapiens (human)0.01

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asakawa, T; Kataoka, O; Moritoh, Y; Odaka, H; Takeuchi, K2
Fujigaki, Y; Fujikura, T; Isobe, S; Iwakura, T; Kato, A; Naito, Y; Ohashi, N; Ono, M; Sakao, Y; Tsuji, N; Tsuji, T; Yasuda, H1

Other Studies

3 other study(ies) available for glucagon and alogliptin

ArticleYear
Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice.
    European journal of pharmacology, 2008, Jul-07, Volume: 588, Issue:2-3

    Topics: Animals; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Glucagon; Glucagon-Like Peptide 1; Insulin; Male; Mice; Mice, Obese; Piperidines; Triglycerides; Uracil

2008
Combining a dipeptidyl peptidase-4 inhibitor, alogliptin, with pioglitazone improves glycaemic control, lipid profiles and beta-cell function in db/db mice.
    British journal of pharmacology, 2009, Volume: 157, Issue:3

    Topics: Adiponectin; Animals; Blood Glucose; Body Weight; Cell Degranulation; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Eating; Glucagon; Glucagon-Like Peptide 1; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Lipids; Male; Mice; Pioglitazone; Piperidines; Thiazolidinediones; Uracil

2009
Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels.
    Medical science monitor : international medical journal of experimental and clinical research, 2014, Apr-10, Volume: 20

    Topics: Aged; Asian People; Body Mass Index; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Japan; Kidney Function Tests; Male; Piperidines; Regression Analysis; Renal Insufficiency, Chronic; Steroids; Uracil; Vital Signs

2014